In line with the reports (Hinz et al. [21]; Cunha et al. [22]), we discovered that FOXP3 was not expressed in normal brain tissues and sporadic expression can be identified in the tumor cells of grade III gliomas, and greater expression, particularly in the nucleus of tumor cells, may be seen in GBM tumors. Here, FOXP3 is linked to central nervous system cancer.